Antitumorigenic effects of cannabinoids beyond apoptosis.

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works

Cell Migration: A Physically Integrated Molecular Process

Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · see citing works

Genes that mediate breast cancer metastasis to lung

Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · see citing works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · see citing works

Anti-Angiogenesis

Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,178 · see citing works

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works

Matrix metalloproteinases in tumor invasion and metastasis

Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 809 · see citing works

Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration

Sieg, D. J., Hauck, C. R., & Schlaepfer, D. D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.16.2677 · Cited by 688 · see citing works

Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

Galve‐Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 684 · see citing works

Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., PETROCELLIS, L. D., Laezza, C., Portella, G., Bifulco, M., & Marzo, V. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 569 · see citing works

Matrix metalloproteinases

Curran, S., & Murray, G. I. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00156-8 · Cited by 537 · see citing works

A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK

Richardson, A., & Parsons, J. T. (1996) · Nature · doi:10.1038/380538a0 · Cited by 484 · see citing works

Antisense RNA-Induced Reduction in Murine TIMP Levels Confers Oncogenicity on Swiss 3T3 Cells

Khokha, R., Waterhouse, P. D., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., & Denhardt, D. T. (1989) · Science · doi:10.1126/science.2465572 · Cited by 451 · see citing works

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

Casanova, M., Blázquez, C., Martínez‐Palacio, J., Villanueva, C., Fernández‐Aceñero, M. J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16116 · Cited by 437 · see citing works

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Sánchez, C., CEBALLOS, M. L. D., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve‐Roperh, I., Huffman, J. W., y Cajal, S. R., & Guzmán, M. (2001) · PubMed · Cited by 424 · see citing works

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

PETROCELLIS, L. D., Melck, D. J., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., & Marzo, V. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8375 · Cited by 412 · see citing works

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

Casanova, M., Blázquez, C., Martínez‐Palacio, J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316116 · Cited by 359 · see citing works

Antineoplastic Activity of Cannabinoids2

Munson, A. E., Harris, L. S., Friedman, M. A., Dewey, W. L., & Carchman, R. A. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/55.3.597 · Cited by 349 · see citing works

Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women

Wall, M. E., Sadler, B. M., Brine, D. R., Taylor, H. L., & Perez‐Reyes, M. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.179 · Cited by 346 · see citing works

Cannabinoid receptors as novel targets for the treatment of melanoma

Blázquez, C., Carracedo, A., Barrado, L., Real, P. J., Fernández-Luna, J. L., Velasco, G., Malumbres, M., & Guzmán, M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 293 · see citing works

Inhibition of tumor angiogenesis by cannabinoids

Blázquez, C., Casanova, M., Planas, A. M., del Pulgar, T. G., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292 · see citing works

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

Costa, B., Giagnoni, G., Franke, C., Trovato, A. E., & Colleoni, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705920 · Cited by 291 · see citing works

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

McKallip, R. J., Lombard, C. A., Fisher, M. T., Martin, B. R., Ryu, S., Grant, S., Nagarkatti, P. S., & Nagarkatti, M. (2002) · Blood · doi:10.1182/blood-2002-01-0098 · Cited by 288 · see citing works

Possible endocannabinoid control of colorectal cancer growth

Ligresti, A., Bisogno, T., Matias, I., PETROCELLIS, L. D., Cascio, M. G., Cosenza, V., D’Argenio, G., Scaglione, G., Bifulco, M., Sorrentini, I., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00881-3 · Cited by 288 · see citing works

Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor

Hart, S., Fischer, O. M., & Ullrich, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3720 · Cited by 288 · see citing works

Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas

Blázquez, C., González‐Feria, L., Álvarez, L., Haro, A., Casanova, M., & Guzmán, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3927 · Cited by 255 · see citing works

Δ-9-Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response

McKallip, R. J., Nagarkatti, M., & Nagarkatti, P. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3281 · Cited by 245 · see citing works

Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells

Suzuma, K., Naruse, K., Suzuma, I., Takahara, N., Ueki, K., Aiello, L. P., & King, G. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006509200 · Cited by 240 · see citing works

Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1

Ramer, R., & Hinz, B. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm268 · Cited by 222 · see citing works

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

McAllister, S. D., Christian, R. T., Horowitz, M. P., García‐Bilbao, A., & Desprez, P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0371 · Cited by 220 · see citing works

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

Fong, S., Itahana, Y., Sumida, T., Singh, J., Coppé, J., Liu, Y., Richards, P. C., Bennington, J. L., Lee, N. M., Debs, R. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2230238100 · Cited by 206 · see citing works

Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration

Bussolati, B., Ahmed, A., Pemberton, H. N., Landis, R. C., Carlo, F. D., Haskard, D. O., & Mason, J. C. (2003) · Blood · doi:10.1182/blood-2003-06-1974 · Cited by 199 · see citing works

Mast cells and cutaneous malignancies

Ch’ng, S., Wallis, R. A., Yuan, L., Davis, P. F., & Tan, S. T. (2005) · Modern Pathology · doi:10.1038/modpathol.3800474 · Cited by 193 · see citing works

Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

Mimeault, M., Pommery, N., Wattez, N., Bailly, C., & Hénichart, J. (2003) · The Prostate · doi:10.1002/pros.10190 · Cited by 191 · see citing works

Caspases Cleave Focal Adhesion Kinase during Apoptosis to Generate a FRNK-like Polypeptide

Gervais, F. G., Thornberry, N. A., Ruffolo, S. C., Nicholson, D. W., & Roy, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17102 · Cited by 191 · see citing works

Mechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor

Galve‐Roperh, I., Rueda, D., del Pulgar, T. G., Velasco, G., & Guzmán, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1385 · Cited by 185 · see citing works

Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis

Portella, G., Laezza, C., Laccetti, P., PETROCELLIS, L. D., Marzo, V. D., & Bifulco, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1129fje · Cited by 184 · see citing works

Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression

Blázquez, C., Salazar‐Roa, M., Carracedo, A., Lorente, M., Egia, A., González‐Feria, L., Haro, A., Velasco, G., & Guzmán, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5176 · Cited by 184 · see citing works

Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo

Preet, A., Ganju, R. K., & Groopman, J. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210641 · Cited by 172 · see citing works

Targeting the endocannabinoid system in cancer therapy: A call for further research

Bifulco, M., & Marzo, V. D. (2002) · Nature Medicine · doi:10.1038/nm0602-547 · Cited by 171 · see citing works

Anandamide inhibits adhesion and migration of breast cancer cells

Grimaldi, C., Pisanti, S., Laezza, C., Malfitano, A. M., Santoro, A., Vitale, M., Caruso, M. G., Notarnicola, M., Iacuzzo, I., Portella, G., et al. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.024 · Cited by 166 · see citing works

Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth

Wang, D., Wang, H., Wei, N., Backlund, M. G., Dey, S. K., & DuBois, R. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0896 · Cited by 166 · see citing works

Cannabinoids and cell fate

Guzmán, M., Sánchez, C., & Galve‐Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 161 · see citing works

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism

Vaccani, A., Massi, P., Colombo, A., Rubino, T., & Parolaro, D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706134 · Cited by 154 · see citing works

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation

Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., & Marzo, V. D. (2004) · The FASEB Journal · doi:10.1096/fj.04-1754fje · Cited by 152 · see citing works

Δ9‐Tetrahydrocannabinol induces apoptosis in human prostate PC‐3 cells via a receptor‐independent mechanism

Ruiz, L., Miguel, A. E., & Díaz‐Laviada, I. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01073-x · Cited by 152 · see citing works

Growth factor–induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen

Seandel, M., Noack–Kunnmann, K., Zhu, D., Aimes, R. T., & Quigley, J. P. (2001) · Blood · doi:10.1182/blood.v97.8.2323 · Cited by 144 · see citing works

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 137 · see citing works

Control by the endogenous cannabinoid system of ras oncogene‐dependent tumor growth

Bifulco, M., Laezza, C., Portella, G., Vitale, M., Orlando, P., PETROCELLIS, L. D., & Marzo, V. D. (2001) · The FASEB Journal · doi:10.1096/fj.01-0320fje · Cited by 137 · see citing works

Suppression of Invasion by Inducible Expression of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in B 16-F10 Melanoma Cells

Khokha, R., Zimmer, M. J., Graham, C. H., Lala, P. K., & Waterhouse, P. D. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.13.1017 · Cited by 135 · see citing works

2-Arachidonoylglycerol

Nithipatikom, K., Endsley, M. P., Isbell, M. A., Falck, J. R., Iwamoto, Y., Hillard, C. J., & Campbell, W. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3136 · Cited by 133 · see citing works

Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor‐suppressor efficacy

Pisanti, S., Borselli, C., Oliviero, O., Laezza, C., Gazzerro, P., & Bifulco, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20954 · Cited by 108 · see citing works

Endogenous Cannabinoid Receptor Ligand Induces the Migration of Human Natural Killer Cells

Kishimoto, S. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi021 · Cited by 96 · see citing works

Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells

Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., & Brune, K. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002618 · Cited by 93 · see citing works

Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression

Hornebeck, W., Lambert, E., Petitfrere, E., & Bernard, P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.022 · Cited by 81 · see citing works

p38 MAPK is involved in CB2 receptor‐induced apoptosis of human leukaemia cells

Herrera, B. M., Carracedo, A., Diez-Zaera, M., Guzmán, M., & Velasco, G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.021 · Cited by 79 · see citing works

A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells

Kogan, N. M., Blázquez, C., Álvarez, L., Gallily, R., Schlesinger, M., Guzmán, M., & Mechoulam, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021089 · Cited by 70 · see citing works

The Synthetic Cannabinoid R(+)WIN 55,212-2 Inhibits the Interleukin-1 Signaling Pathway in Human Astrocytes in a Cannabinoid Receptor-independent Manner

Curran, N., Griffin, B. D., O’Toole, D. P., Brady, K. J., Fitzgerald, S. N., & Moynagh, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507959200 · Cited by 69 · see citing works

HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor

Kogan, N. M., Schlesinger, M., Priel, E., Rabinowitz, R., Berenshtein, E., Chevion, M., & Mechoulam, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0039 · Cited by 68 · see citing works

Differential requirement of protein tyrosine kinases and protein kinase C in the regulation of T cell locomotion in three-dimensional collagen matrices

Entschladen, F., Niggemann, B., Zänker, K. S., & Friedl, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3203 · Cited by 66 · see citing works

Cannabinoid derivatives induce cell death in pancreatic MIA PaCa‐2 cells via a receptor‐independent mechanism

Fogli, S., Nieri, P., Chicca, A., Adinolfi, B., Mariotti, V., Iacopetti, P., Breschi, M. C., & Pellegrini, S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.024 · Cited by 62 · see citing works

AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo

Zacchigna, S., Zentilin, L., Morini, M., Dell’Eva, R., Noonan, D. M., Albini, A., & Giacca, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700657 · Cited by 57 · see citing works

Molecular Biology of Cannabinoid Receptors

Abood, M. E. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_3 · Cited by 56 · see citing works

Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

Blázquez, C., Carracedo, A., Salazar‐Roa, M., Lorente, M., Egia, A., González‐Feria, L., Haro, A., Velasco, G., & Guzmán, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.021 · Cited by 50 · see citing works

Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: Role of nuclear factor‐κB and reactive oxygen species

Park, M., Lee, J., Kwak, H., Park, C., Lee, H.-C., Woo, S. H., Jin, H., Han, C., An, S., Lee, S., et al. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20452 · Cited by 41 · see citing works

SEL1L Affects Human Pancreatic Cancer Cell Cycle and Invasiveness through Modulation of PTEN and Genes Related to Cell-Matrix Interactions

Cattaneo, M., Fontanella, E., Canton, C., Delia, D., & Biunno, I. (2005) · Neoplasia · doi:10.1593/neo.05451 · Cited by 41 · see citing works

Adenovirus‐mediated expression of TIMP‐1 and TIMP‐2 in bone inhibits osteolytic degradation by human prostate cancer

Deng, X., He, G., Levine, A. L., Cao, Y., & Mullins, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23053 · Cited by 40 · see citing works

The Influence of Mast Cell Mediators on Migration of SW756 Cervical Carcinoma Cells

Rudolph, M. I., Oreamuno, M. Y. V. B., Yefi, R., Luza, S., Andrews, E. M., Penissi, A. B., Garrido, P., & Rojas, I. G. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070736 · Cited by 39 · see citing works

The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway

Laezza, C., Pisanti, S., Malfitano, A. M., & Bifulco, M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0030 · Cited by 39 · see citing works

Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells

Ramer, R., Eichele, K., & Hinz, B. (2007) · Oncogene · doi:10.1038/sj.onc.1210358 · Cited by 37 · see citing works

Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell

Chan, V. Y. W., Chan, M. W. Y., Leung, W. K., Leung, P. S., Sung, J. J. �., & Chan, F. K. L. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.016 · Cited by 33 · see citing works

Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells

Park, H. J., Lee, H., Min, H., Chung, H., Suh, M., Choo, H. P., Kim, C., Kim, H. J., Seo, E., & Lee, S. K. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.009 · Cited by 20 · see citing works

CB1 cannabinoid receptor‐mediated tyrosine phosphorylation of focal adhesion kinase‐related non‐kinase

Zhou, D., & Song, Z. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03091-0 · Cited by 18 · see citing works

Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy

Saia, G., Zhang, M., Depalo, V., Lautenschlaeger, T., & Chakravarti, A. (2007) · Current Cancer Therapy Reviews · doi:10.2174/157339407780126647 · Cited by 5 · see citing works

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer

Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L. (2018) · BioMed Research International · doi:10.1155/2018/1691428 · Cited by 375 · see citing works

Cannabidiol as potential anticancer drug

Massi, P., Solinas, M., Cinquina, V., & Parolaro, D. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04298.x · Cited by 231 · see citing works

COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells

Ramer, R., Heinemann, K., Merkord, J., Rohde, H., Salamon, A., Linnebacher, M., & Hinz, B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0335 · Cited by 202 · see citing works

Cannabinoids as therapeutic agents in cancer: current status and future implications

Chakravarti, B., Ravi, J., & Ganju, R. K. (2014) · Oncotarget · doi:10.18632/oncotarget.2233 · Cited by 219 · see citing works

Cannabidiol inhibits angiogenesis by multiple mechanisms

Solinas, M., Massi, P., Cantelmo, A. R., Cattaneo, M. G., Cammarota, R., Bartolini, D., Cinquina, V., Valenti, M., Vicentini, L. M., Noonan, D. M., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02050.x · Cited by 167 · see citing works

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

McAllister, S. D., Soroceanu, L., & Desprez, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9608-y · Cited by 139 · see citing works

Population‐based case‐control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk

Lacson, J. C. A., Carroll, J. D., Tuazon, E. D., Castelao, E., Bernstein, L., & Cortessis, V. K. (2012) · Cancer · doi:10.1002/cncr.27554 · Cited by 120 · see citing works

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

Haustein, M., Ramer, R., Linnebacher, M., Manda, K., & Hinz, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.014 · Cited by 102 · see citing works

Cannabinoids in the Pathophysiology of Skin Inflammation

Scheau, C., Bădărău, I. A., Mihai, L.-G., Scheau, A.-E., Costache, D. O., Constantin, C., Călina, D. C., Căruntu, C., Costache, R. S., & Căruntu, A. (2020) · Molecules · doi:10.3390/molecules25030652 · Cited by 98 · see citing works

Cannabinoids as anticancer therapeutic agents

Kovalchuk, O., & Kovalchuk, I. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1742952 · Cited by 96 · see citing works

Monoacylglycerol lipase – a target for drug development?

Fowler, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01950.x · Cited by 95 · see citing works

Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators

Brown, I. M., Cascio, M. G., Rotondo, D., Pertwee, R. G., Heys, S. D., & Wahle, K. W. J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.001 · Cited by 94 · see citing works

Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells

Ramer, R., Rohde, A., Merkord, J., Rohde, H., & Hinz, B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0219-2 · Cited by 91 · see citing works

Cannabinoid receptor‐2 agonist inhibits macrophage induced EMT in non‐small cell lung cancer by downregulation of EGFR pathway

Ravi, J., Elbaz, M., Wani, N. A., Nasser, M. W., & Ganju, R. K. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22451 · Cited by 83 · see citing works

Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4

Thors, L., Bergh, A. R. J., Persson, E., Hammarsten, P., Stattin, P. E., Egevad, L., Granfors, T., & Fowler, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012275 · Cited by 74 · see citing works

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells

Ramer, R., Fischer, S. B., Haustein, M., Manda, K., & Hinz, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.017 · Cited by 73 · see citing works

Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer

Greish, K. F., Mathur, A., Alzahrani, R., Elkaissi, S., Aljishi, M., Nazzal, O., Taha, S., Pittalà, V., & Taurin, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.030 · Cited by 70 · see citing works

High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer

Gustafsson, S. B., Palmqvist, R., Henriksson, M. L., Dahlin, A. M., Edin, S., Jacobsson, S. O. P., Öberg, Å., & Fowler, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023003 · Cited by 70 · see citing works

Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells

Gęgotek, A., Nikliński, J., Žarković, N., Žarković, K., Waeg, G., Łuczaj, W., Charkiewicz, R., & Skrzydlewska, E. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.010 · Cited by 68 · see citing works

The clinical significance of endocannabinoids in endometriosis pain management

Bouaziz, J., Bar On, A., Seidman, D. S., & Soriano, D. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0035 · Cited by 65 · see citing works

Endocannabinoid involvement in endometriosis.

Dmitrieva, N., Nagabukuro, H., Resuehr, D., Zhang, G., McAllister, S. L., McGinty, K. A., Mackie, K., & Berkley, K. J. (2010) · Pain · doi:10.1016/j.pain.2010.08.037 · Cited by 64 · see citing works

Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors

Messalli, E. M., Grauso, F., Luise, R., Angelini, A., & Rossiello, R. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.04.004 · Cited by 58 · see citing works

Antitumorigenic targets of cannabinoids – current status and implications

Ramer, R., & Hinz, B. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1177512 · Cited by 43 · see citing works

Delta9‐tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature

Fowler, C. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.84 · Cited by 44 · see citing works

Can cannabidiol inhibit angiogenesis in colon cancer?

Honarmand, M., Namazi, F., Mohammadi, A., & Nazıfı, S. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-018-2810-6 · Cited by 42 · see citing works

Cannabinoid-associated cell death mechanisms in tumor models

Calvaruso, G., Pellerito, O., Notaro, A., & Giuliano, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1476 · Cited by 41 · see citing works

The endocannabinoid system: A novel player in human placentation

Costa, M. A. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.03.002 · Cited by 39 · see citing works

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells

Nithipatikom, K., Gomez-Granados, A. D., Tang, A. T., Pfeiffer, A. W., Williams, C. L., & Campbell, W. B. (2011) · Endocrinology · doi:10.1210/en.2011-1144 · Cited by 38 · see citing works

The molecular connections between the cannabinoid system and endometriosis

Sanchez, A. M., Viganò, P., Mugione, A., Panina‐Bordignon, P., & Candiani, M. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas037 · Cited by 35 · see citing works

The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?

Waissengrin, B., Leshem, Y., Taya, M., Meiri, D., Merimsky, O., Shamai, S., Wolf, I., & Rubinek, T. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.022 · Cited by 32 · see citing works

Expression and functionality of TRPV1 receptor in human MCF ‐7 and canine CF .41 cells

Vercelli, C., Barbero, R., Cuniberti, B., Odore, R., & Re, G. (2013) · Veterinary and Comparative Oncology · doi:10.1111/vco.12028 · Cited by 29 · see citing works

The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines

Müller, L., Radtke, A., Decker, J., Koch, M., & Belge, G. (2017) · Anticancer Research · doi:10.21873/anticanres.12086 · Cited by 27 · see citing works

Appraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic Diseases

Azam, M. N. K., Rahman, M., Biswas, S., & Ahmed, M. N. (2016) · International Scholarly Research Notices · doi:10.1155/2016/7832120 · Cited by 27 · see citing works

WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner

Notaro, A., Emanuele, S., Geraci, F., D’Anneo, A., Lauricella, M., Calvaruso, G., & Giuliano, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205235 · Cited by 26 · see citing works

Understanding the Placental Biology of Tobacco Smoke, Nicotine, and Marijuana (THC) Exposures During Pregnancy

Banerjee, S., DEACON, A., Suter, M., & Aagaard, K. M. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000691 · Cited by 24 · see citing works

Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer

Cipriano, M., Häggström, J., Hammarsten, P., & Fowler, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065798 · Cited by 25 · see citing works

The role of cannabinoids in the treatment of cancer

Večeřa, L., Gabrhelik, T., Prasil, P., & Štourač, P. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_012 · Cited by 24 · see citing works

Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer

Fowler, C. J., Hammarsten, P., & Bergh, A. R. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015205 · Cited by 21 · see citing works

A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation

Scarpelli, R., Sasso, O., & Piomelli, D. (2015) · ChemMedChem · doi:10.1002/cmdc.201500395 · Cited by 21 · see citing works

An Ethnobotanical and Ethnopharmacological Survey of Cannabis sativa of Taounate Region in Northern Morocco

Bouarfa, M., Lebtar, S., Boukhira, S., & Bousta, D. (2020) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2020.v64i02.019 · Cited by 19 · see citing works

Cannabinoids in Gynecological Diseases

Luschnig, P., & Schicho, R. (2019) · Medical Cannabis and Cannabinoids · doi:10.1159/000499164 · Cited by 19 · see citing works

New Insights into Antimetastatic and Antiangiogenic Effects of Cannabinoids

Ramer, R., & Hinz, B. (2014) · International review of cytology · doi:10.1016/bs.ircmb.2014.10.005 · Cited by 19 · see citing works

Anti-tumor Activity of the Novel Hexahydrocannabinol Analog LYR-8 in Human Colorectal Tumor Xenograft Is Mediated through the Inhibition of Akt and Hypoxia-Inducible Factor-1α Activation

Thapa, D., Kang, Y., Park, P., Noh, S. K., Lee, Y. R., Han, S. S., Ku, S., Jung, Y., & Kim, J. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.924 · Cited by 19 · see citing works

The evolving role of the endocannabinoid system in gynaecological cancer

Ayakannu, T., Taylor, A. H., Willets, J. M., & Konje, J. C. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv022 · Cited by 18 · see citing works

(Endo)Cannabinoids and Gynaecological Cancers

Taylor, A. H., Tortolani, D., Ayakannu, T., Konje, J. C., & Maccarrone, M. (2020) · Cancers · doi:10.3390/cancers13010037 · Cited by 16 · see citing works

Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model

Ökten, S. B., Çetin, Ç., Tok, O. E., Güler, E. M., Taha, S. H., Özcan, P., & Fıçıcıoğlu, C. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.01.018 · Cited by 16 · see citing works

The pharmacological basis for application of cannabidiol in cancer chemotherapy

Zhelyazkova, M., Kirilov, B., & Momekov, G. (2020) · Pharmacia · doi:10.3897/pharmacia.67.e51304 · Cited by 16 · see citing works

Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations

Björklund, E., Larsson, T. N. L., Jacobsson, S. O. P., & Fowler, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087542 · Cited by 12 · see citing works

Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

Buchtova, T., Skrott, Z., Chroma, K., Rehulka, J., Dzubak, P., Hajduch, M., Lukac, D., Arampatzis, S., Bartek, J., & Mistrik, M. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13114 · Cited by 11 · see citing works

The antitumor action of cannabinoids on glioma tumorigenesis.

Zogopoulos, P., Korkolopoulou, P. A., Patsouris, E., & Theocharis, S. E. (2015) · PubMed · doi:10.14670/hh-30.629 · Cited by 11 · see citing works

Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: A Bayesian network analysis of data from a tissue microarray

Häggström, J., Cipriano, M., Forshell, L. P., Persson, E., Hammarsten, P., Stella, N., & Fowler, C. J. (2014) · The Prostate · doi:10.1002/pros.22827 · Cited by 9 · see citing works

Cannabidiol and Cancer — An Overview of the Preclinical Data

Solinas, M., Cinquina, V., & Parolaro, D. (2015) · InTech eBooks · doi:10.5772/59193 · Cited by 9 · see citing works

Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells

Gholizadeh, F., Ghahremani, M. H., Aliebrahimi, S., Shadboorestan, A., & Ostad, S. N. (2019) · Iranian Biomedical Journal · doi:10.29252/ibj.23.2.153 · Cited by 9 · see citing works

Multi-charged nanoemulsion for photodynamic treatment of glioblastoma cell line in 2D and 3D in vitro models

Borges, H. S., Gusmão, L. A., & Tedesco, A. C. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103723 · Cited by 7 · see citing works

Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells

Tong, S., Loilome, W., Namwat, N., Klanrit, P., Wangwiwatsin, A., Win, Z. Z., Koyabuth, P., & Chumworathayi, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1693129 · Cited by 6 · see citing works

Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment

Bachari, A., Nassar, N., Schanknecht, E., Telukutla, S. R., Piva, T. J., & Mantri, N. L. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1633 · Cited by 6 · see citing works

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer

Fowler, C. J., Josefsson, A., Thors, L., Chung, S. C., Hammarsten, P., Wikström, P., & Bergh, A. R. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.12.005 · Cited by 6 · see citing works

Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

Tahermanesh, K., Hakimpour, S., Govahi, A., Keyhanfar, F., Mehdizadehkashi, A., Chaichian, S., Shahriyaripour, R., & Ajdary, M. (2022) · BioMed Research International · doi:10.1155/2022/1111777 · Cited by 5 · see citing works

Clearing The Smoke On Cannabis

Meducator, T., Cui, E., & Rayner, D. G. (2019) · The Meducator · doi:10.15173/m.v1i35.2207 · Cited by 5 · see citing works

Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212–2 administration in mice

Omran, G. A., Allah, E. S. H. A., Mohammed, S. A., & Shehaby, D. M. E. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00644-3 · Cited by 5 · see citing works

Cannabinoids and Endocannabinoids

Jung, K., & Piomelli, D. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_136-1 · Cited by 4 · see citing works

Cannabinoids and Endocannabinoids

Jung, K., & Piomelli, D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3474-4_136 · Cited by 4 · see citing works

Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line.

Vaseghi, G., Taki, M. J., & Javanmard, S. H. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.9398 · Cited by 3 · see citing works

Transient Receptor Potential Vanilloid 1 in animal tissues: An overview to highlight similarities and differences with human species

Vercelli, C., Barbero, R., & Re, G. (2015) · Receptors & Clinical Investigation · doi:10.14800/rci.646 · Cited by 3 · see citing works

Cancer therapy – The role of cannabinoids and endocannabinoids

(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.583 · Cited by 2 · see citing works

Medicinal Applications of Cannabidiol from the Genus Cannabis L.

Bag, D., Tabassum, A., Arora, N., Verma, P. K., & Sawant, S. D. (2020) · Springer eBooks · doi:10.1007/978-981-15-5917-4_10 · Cited by 2 · see citing works

The Role of the Endocannabinoid System in the Gynaecological MalignancyPreprint

Grauso, F., Autiero, R., Lannino, G. R., Zizolfi, B., Perone, C., & Messalli, E. M. (2018) · Preprints.org · doi:10.20944/preprints201806.0001.v1 · Cited by 1 · see citing works

The Webscout

Eichele, K., Faoite, D. D., & Wicki, B. (2012) · Medical Writing · doi:10.1179/204748112x13329478948652

Desenvolvimento e caracterização de nanoemulsão multi-carregada: protoporfirina IX, indocianina verde e CBD para tratamento de glioblastoma por terapia fotodinâmica

Borges, H. S. (2023) · doi:10.11606/d.59.2023.tde-04102023-132705

Ethnopharmacology of Cannabis sativa: Unveiling the Medicinal Heritage and Modern Applications

Laxmi, V., & Martolia, J. (2025) · Journal of Natural Remedies · doi:10.18311/jnr/2025/47860

Additional file 1 of Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212–2 administration in mice

Omran, G. A., Allah, E. S. H. A., Mohammed, S. A., & Shehaby, D. M. E. (2023) · Figshare · doi:10.6084/m9.figshare.22610365

Anticancer Mechanisms of Cannabinoids

Velasco, G., Sánchez, C., & Guzmán, M. (2016) · Current Oncology · doi:10.3747/co.23.3080 · Cited by 268 · see citing works

New Insights into Antimetastatic and Antiangiogenic Effects of Cannabinoids

Ramer, R., & Hinz, B. (2014) · International review of cytology · doi:10.1016/bs.ircmb.2014.10.005 · Cited by 19 · see citing works

Cancer

Velasco, G., Sánchez, C., & Guzmán, M. (2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.003.0035 · Cited by 2 · see citing works

Cannabinoid-associated cell death mechanisms in tumor models

Calvaruso, G., Pellerito, O., Notaro, A., & Giuliano, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1476 · Cited by 41 · see citing works

Inhibition of tumor angiogenesis by cannabinoids

Blázquez, C., Casanova, M., Planas, A. M., del Pulgar, T. G., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292 · see citing works